Latest Regulatory Challenges News

Macquarie Group Limited reported a 3% increase in half-year profit to $1.655 billion, driven by growth across its asset management, banking, commodities, and capital markets divisions. The group maintains robust capital and liquidity positions despite margin pressures and regulatory challenges.

Black Dragon Gold has withdrawn its application to classify the Salave Gold Project as a Project of Strategic Interest in Asturias, Spain, planning a stronger resubmission backed by legal clarity and community support.

Admiralty Resources NL reported steady production growth at its Mariposa Iron Ore Project in Chile, securing key export approvals and infrastructure progress despite a delay in its audited financial statements that led to ASX suspension.

The Star Entertainment Group reported a 5% revenue increase in Q1 FY26 and a halving of its EBITDA loss, while navigating regulatory challenges and advancing a major joint venture exit.

Bulletin Resources has significantly expanded its Lake Rebecca Gold Project, nearly doubling its size through strategic acquisitions, while facing regulatory challenges at its Ravensthorpe Lithium Project. The company maintains a robust financial position as it plans targeted drilling and reviews next steps.

Titanium Sands Limited is advancing its Mannar Island Project with the Environmental Impact Assessment nearing completion and secured funding to navigate regulatory hurdles in Sri Lanka.

Taruga Minerals has secured new exploration licences in Western Australia’s Gascoyne province and identified a promising gold and copper prospect, reinforcing its position in polymetallic exploration.

EQT Holdings Limited reported a robust 60% increase in net profit after tax for FY25, completing a strategic transformation while navigating significant regulatory challenges. The company outlined a growth-focused strategy for FY26, emphasizing digital innovation and margin improvement.

Dubber Corporation Limited reported its first-ever positive net operating cashflow excluding exceptional items in Q1 FY26, supported by cost savings and a strong cash position. The company also expanded its partner network and targets operating cashflow breakeven this fiscal year.

Tissue Repair Limited reports steady progress in its Phase 3 clinical trials for chronic wound treatment and advances regulatory filings for its TR Pro+® product, while gearing up for a major commercial rollout in early 2026.

Equatorial Resources reports a postponed arbitration hearing over Congo iron ore disputes and seeks clarity on Guinea permit cancellations, while maintaining a solid cash reserve.

Medibank has set ambitious goals to triple its health segment earnings by FY30, expand its private health insurance market share, and double its health engagement, signaling a strategic pivot towards integrated, technology-driven care.